Bloodborne Pathogens: Exposure In The Workplace - English DVDHelp meet OSHA's Bloodborne Pathogens Standard (29 CFR 1910.1030) OSHA's Bloodborne Pathogens Standard (29 CFR 1910.1030) requires organizations to provide training to general industry employees who could be exposed to bloodborne pathogens as part of their job duties. They are also responsible for developing an Exposure Control Plan. However, the possibility of exposure to bloodborne pathogens is a risk to all employees, making awareness-level training a good practice. J. J. Keller's all-new Bloodborne Pathogens: Exposure In The Workplace covers what bloodborne pathogens are, why you don't want to be exposed, and what you can do to prevent exposures. Bloodborne Pathogens: Exposure In The Workplace uses a "risk scenario" that tracks through a bloodborne pathogens exposure, and shows employees how to react - and how not to react - to an injury involving blood. It also features information that must be included in training, per OSHA's Bloodborne Pathogens Standard (29 CFR 1910.1030): - Bloodborne diseases and how they are spread.
- Info on the Exposure Control Plan.
- Engineering, work, and practice controls.
- Personal Protective Equipment (PPE).
- How to respond to emergencies involving blood.
- Hepatitis B vaccine, exposure evaluation and follow up.
- Signs and labels used to warn of potential hazards (e.g., biohazard symbol).
This training program comes with the following training tools: - (1) 22-Minute closed-captioned video - Available on DVD (with extra bonus features) , the program combines engaging video and editing technology with expertise from industry professionals at all levels.
- (1) Instructor's Guide - Provides you with background information and training tips to make the most out of each training session.
- (11) Employee Handbooks - Reviews key points and includes a quiz to check trainees' understanding of the material. Also includes a training receipt page.
- (1) Trainer Tools CD-ROM - CD-ROM includes supplementary information, including content for audiovisual presentations/handouts, quizzes, answer keys, clip art, posters, and a training log. These items can be used as-is, customized, or imported into PowerPoint presentations.(CD-ROM not sold separately).
- (1) Awareness Poster - Hang in a break room or training area to provide a daily reminder of the importance of protecting yourself against bloodborne pathogens.
The Bloodborne Pathogens: Exposure in the Workplace Training Program is available on DVD. DVD's provide added features! DVD Main Menu - Play Program - Plays entire main program.
- Chapter Selections Allows easy access to specific subtopics for more focused training.
- Bonus Materials
- Review - Narrated- and graphic-supported review of video.
- Commentary Offers additional interviews by industry professionals.
- Quiz 10 interactive questions; offers correct/incorrect remediation to reinforce effectiveness of training.
- Message for Management - Introduction to program for trainer and/or management.
Main information table containing FAQs on Bloodborne Pathogens Are employers responsible for providing sharps containers for employees who are diabetic and need insulin shots in a non-health care related facility?
The Bloodborne Pathogens Standard only applies to occupational exposure to blood. The employer would not be required to provide a sharps container to an employee using insulin syringes for personal therapeutic reasons. In order to eliminate potential exposures to other workers, the employer should strongly insist that the employee have his or her own sharps container and bring that with them to the workplace.
Reference Interpretation and Compliance Letters:
A review of the initial intent of the Bloodborne Pathogens Standard that specifically deals with the cleaning of contaminated work surfaces, i.e., 1910.1030(d)(4)(ii)(A), reveals that OSHA intended to provide a performance-based provision that would allow for future development of "appropriate disinfectant" products. OSHA has reviewed the information on the disinfectants and has reconsidered its position on EPA-registered disinfectants that are labeled as effective against HBV and HIV. OSHA's current stance is that EPA-registered disinfectants for HIV and HBV meet the requirement in the standard and are "appropriate" disinfectants to clean contaminated surfaces, provided such surfaces have not become contaminated with agent(s) or volumes of or concentrations of agent(s) for which higher level disinfection is recommended.
It is important to emphasize the EPA-approved label section titled "SPECIAL INSTRUCTIONS FOR CLEANING AND DECONTAMINATION AGAINST HIV-1 AND HBV Of SURFACES\OBJECTS SOILED WITH BLOOD\BODY FLUIDS." On the labels that OSHA has seen, these instructions require: 1) personal protection devices for the worker performing the task; 2) that all the blood must be cleaned thoroughly before applying the disinfectant; 3) that the disposal of the infectious waste is in accordance with federal, state, or local regulations; 4) that the disposal of the infectious waste is in accordance with federal, state, or local regulations; and 5) that the surface is left wet with the disinfectant for 30 seconds for HIV-1 and 10 minutes for HBV. OSHA would expect all such disinfectants to be used in accordance with their EPA-approved label instructions.
Reference Interpretation and Compliance Letters:
[29 CFR 1910.1030(f)(1)(ii)(D)] takes into consideration the changing nature of medical treatment relating to Hepatitis B. The CDC is the U.S. Public Health Service (USPHS) agency responsible for issuing guidelines and making recommendations regarding infectious agents. OSHA requires use of the CDC guidelines current at the time of the evaluation or procedure. Copies of the current guidelines and other CDC documents can be obtained on CDC's web site, http://www.cdc.gov. The hepatitis B vaccination must be given in the standard dose and through the standard route of administration as recommended in the USPHS/CDC guidelines. The most current CDC guideline regarding Hepatitis B is Immunization of Health-Care Workers: Recommendations of ACIP and HICPAC in Vol. 46, No RR-18, published in the 12/26/1997 MMWR. It recommends that employees who have ongoing contact with patients or blood and are at on going risk for injuries with sharp instruments or needlesticks be tested for antibody to Hepatitis B surface antigen, one to two months after the completion of the three-dose vaccination series. Employees who do not respond to the primary vaccination series must be revaccinated with a second three-dose vaccine series and retested. Non-responders must be medically evaluated.
Reference Interpretation and Compliance Letters: 
| 
